NCT03957291

Brief Summary

  1. 1.Is to assess the efficacy of preoperative disinfection with chlorohexidine and povidone iodine in different concentrations separately .
  2. 2.Is to compare the efficacy of chlorohexidine to povidone iodine.
  3. 3.Compare patient comfort after instillation of each disinfectant .
  4. 4.To find which disinfectant is more effective tolerated and more safe for use .

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Aug 2019

Typical duration for early_phase_1

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 18, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 21, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2019

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

May 21, 2019

Status Verified

May 1, 2019

Enrollment Period

3 years

First QC Date

May 18, 2019

Last Update Submit

May 20, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Patient Comfort

    Patient Comfort using the Wong Baker FACES Pain Scale \[Scale: 0(No pain) - 10 (Worst Pain)\]

    day three post operative

Secondary Outcomes (2)

  • Culture of conjunctiva for bacteria

    7 days

  • Patient Comfort

    I minute after disinfectant drop instilled

Study Arms (2)

Povidine-Iodine

ACTIVE COMPARATOR

patients receiving Povidine-Iodine in right eye, chlorhexidine in the left eye before operation

Drug: Povidone-Iodine

chlorhexidine

ACTIVE COMPARATOR

patients receiving Povidine-Iodine in left eye, chlorhexidine in the right eye before operation

Drug: Chlorhexidine

Interventions

chlorhexidine administration prior to ophthalmic surgery (compared to Povidine iodine )

Also known as: aqueous Chlorhexidine
chlorhexidine

Povidine iodine administration prior to ophthalmic surgery (compared to chlorhexidine)

Also known as: betadine
Povidine-Iodine

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Current patient of the Assiute University Hospital arranged for ophthamic surgery
  • Age greater than 12.

You may not qualify if:

  • Documented allergy to PI or AC
  • Current diagnosis of infectious keratitis
  • History of unilateral contact lens wear in the past 30 days
  • Current unilateral use of prescription eye drops.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Grzybowski A, Kanclerz P, Myers WG. The use of povidone-iodine in ophthalmology. Curr Opin Ophthalmol. 2018 Jan;29(1):19-32. doi: 10.1097/ICU.0000000000000437.

    PMID: 28984794BACKGROUND

MeSH Terms

Interventions

ChlorhexidinePovidone-Iodine

Intervention Hierarchy (Ancestors)

BiguanidesGuanidinesAmidinesOrganic ChemicalsIodophorsIodine CompoundsInorganic ChemicalsPolyvinylsVinyl CompoundsAlkenesHydrocarbons, AcyclicHydrocarbonsPovidonePyrrolidinonesPyrrolidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPlasticsPolymersMacromolecular SubstancesBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and Agriculture

Central Study Contacts

asmaa mohamed, master

CONTACT

Prof. Mohamed Tarek Abdel-Monaem Abdel-Monaem, pHD

CONTACT

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The participant will be masked to which drug they receive, the investigator performing the analysis will also be masked
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomized prospective trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asmaa Mohamed Mostafa

Study Record Dates

First Submitted

May 18, 2019

First Posted

May 21, 2019

Study Start

August 1, 2019

Primary Completion

August 1, 2022

Study Completion

December 1, 2022

Last Updated

May 21, 2019

Record last verified: 2019-05